Heart attack patients get new drug in race to save heart muscle
Disease control
Recruiting now
This study tests whether giving a PCSK9 inhibitor (alirocumab) right after a heart attack and for 3 months afterward helps the heart recover more than standard care alone. About 160 adults with a severe type of heart attack will be split into two groups. The main goal is to see i…
Phase: PHASE4 • Sponsor: Shanghai Tong Ren Hospital • Aim: Disease control
Last updated May 12, 2026 13:39 UTC